Olympic athletes are praising CBD but it s proving controversial Here s why euronews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euronews.com Daily Mail and Mail on Sunday newspapers.
(1)
Khiron is a founding member of Project Twenty 21 and was the first supplier of EU-GMP high-THC dried cannabis flower to the study
The findings show that medical Cannabis dramatically improves quality of life for people with life-limiting conditions, including Chronic Pain, Multiple Sclerosis, Tourette s Syndrome and PTSD
Legal prescriptions allow patients to access medical cannabis without engaging in criminality and to avoid dependency associated with other medicines commonly prescribed for these debilitating conditions
TORONTO, May 11, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal Psychopharmacology of the first findings arising from Project Twenty 21, UK s first and largest national medical cannabis registry that was launched on November
Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK s Cellen Therapeutics to Improve Clinician Education
USA - English
Share this article
Share this article
UK medical professionals may now earn CPD credits through Khiron s medical cannabis education program
The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training
TORONTO, April 13, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce it has received UK Continuing Professional Development ( CPD ) accredita
Published:
5:14 PM February 15, 2021
Matt and Ali Hughes are seeking to have cannabis-based medicinal products more widely prescribed on NHS.
- Credit: Denise Bradley
Parents of a three-year-old boy with severe epilepsy are in negotiations to settle a challenge to guidelines that they hope will encourage prescription of cannabis on the NHS.
Charlie Hughes was diagnosed with West Syndrome - a rare epileptic condition which causes him to suffer up to 120 seizures a day - when he was just 10 weeks old.
Charlie Hughes was diagnosed with West Syndrome - a rare epileptic condition which caused him to suffer up to 120 seizures a day.
Khiron Provides Year-End Corporate Update morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.